3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
47
Precursor Cell Lymphoblastic Leukemia-Lymphoma
32
Myelodysplastic Syndromes
27
Recurrence
20
Multiple Myeloma
20
Lymphoma, Non-Hodgkin
15
Lymphoma
15
Lymphoma, B-Cell
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Hematologic Neoplasms
13
Ovarian Neoplasms
11
Myeloproliferative Disorders
10
Melanoma
10
Leukemia
10
Burkitt Lymphoma
10
Hodgkin Disease
9
Pancreatic Neoplasms
8
Lymphoma, Large B-Cell, Diffuse
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Leukemia, Biphenotypic, Acute
8
Stomach Neoplasms
7
Leukemia, Myelomonocytic, Chronic
7
Colorectal Neoplasms
7
Triple Negative Breast Neoplasms
6
Osteosarcoma
6
Neuroblastoma
6
Neoplasms
6
Lymphoma, Mantle-Cell
6
Lymphoma, Follicular
6
Leukemia, Myelomonocytic, Juvenile
6
Interventions
Dexamethasone
2
Cyclophosphamide
2
Clinical Protocols
2
Bortezomib
2
daratumumab
1
Tissue Banks
1
Rifaximin
1
Clonal Hematopoiesis
1
Chromatin Immunoprecipitation Sequencing
1
CLR1404
1
Blood Cell Count
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Paraproteinemias
×
fludarabine
×
90 days
×
Clear all
No trials found.